NCT05648981

Diode Laser on the Reversal of Inferior Alveolar Nerve Block Anesthesia in Children

Name: Clinical Trial NCT05648981
Creator: Hams Hamed Abdelrahman
Keywords: Anesthesia, Local, Inferior Alveolar Nerve Block administration with laser irradiation, other, clinical trial, Egypt

Effectiveness of Photobiomodulation Using Diode Laser on the Reversal of Inferior Alveolar Nerve Block Anesthesia in Children: a Randomized Controlled Clinical Trial

Hams Hamed Abdelrahman·ClinicalTrials.gov·otherNot yet recruiting

View on ClinicalTrials.gov →

Study focus

Disease/Condition: Anesthesia, Local
Drug/Device/Intervention: Inferior Alveolar Nerve Block administration with laser irradiation
Study type: Interventional
Intervention type: other

Sponsor & location

Primary sponsor: Hams Hamed Abdelrahman
Funder: Alexandria University
Location: Alexandria, Egypt

Timeline & enrollment

Phase: N/A
Start date: Nov 02, 2022
End date: Dec 30, 2022
Enrollment: 32 participants

Primary outcome

Time to recovery of normal lip sensation

Summary

Inevitable problems were reported following the injection of local anesthesia in pediatric dental procedures, which can last until the elimination of soft tissue anesthesia.  Purpose of the study: To evaluate the effectiveness of diode laser photobiomodulation therapy on the reversal of soft tissue anesthesia (STA) in children following inferior alveolar nerve block anesthesia.

ICD-10 classifications

Local anaestheticsAnaesthetic, unspecifiedOther and unspecified general anaestheticsPoisoning: Local anaestheticsParenteral anaesthetics

Data source

Registry: ClinicalTrials.gov
Trial ID: NCT05648981
Type: Non-Device Trial

About this record

Access comprehensive clinical trial information for NCT05648981 through Pure Global AI's free database. This phase not specified trial is sponsored by Hams Hamed Abdelrahman and is currently Not yet recruiting. The study focuses on Anesthesia, Local. Target enrollment is 32 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.